Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4103/1319-2442.308367 | DOI Listing |
Hepatology
May 2024
Department of Specialistic Medicines, Gastroenterology Unit, University of Modena & Reggio Emilia, University Hospital of Modena and Reggio Emilia, Modena, Italy.
Background And Aims: A simple noninvasive score, the Agile 3+ score, combining liver stiffness measurement, aspartate aminotransferase/alanine aminotransferase ratio, platelet count, diabetes status, sex, and age, has been proposed for the identification of advanced fibrosis in patients with suspected NAFLD. We performed a systematic review and meta-analysis of observational studies to evaluate the diagnostic accuracy of the Agile 3+ score in identifying patients with NAFLD and advanced fibrosis. Recently, an International consensus changed the nomenclature of NAFLD into metabolic-associated steatotic liver disease, so currently, the two terms are interchangeable.
View Article and Find Full Text PDFOsteoporos Int
October 2023
Division of Nephrology & Bone and Mineral Metabolism, University of Kentucky, Lexington, KY, USA.
Osteoporos Int
October 2023
Department of Biomedicine, Unit of Biochemistry, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal.
Eur Urol Focus
November 2023
NYU Langone Health, New York, NY, USA.
Background: UGN-101 can be used for chemoablation of low-grade upper tract urothelial carcinoma (UTUC). The gel can be administered via a retrograde route through a ureteral catheter or an antegrade route via a nephrostomy tube.
Objective: To report outcomes of UGN-101 by route of administration.
Clin Mol Hepatol
April 2023
Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!